Announced
Financials
Tags
pharmaceutical products
Private
Pending
Cross Border
Acquisition
Pharmaceuticals
Friendly
Majority
Single Bidder
United Kingdom
Synopsis
NextPharma, a European pharmaceutical Contract Development and Manufacturing Organisation, agreed to acquire two sites of Lonza, a Swiss multinational chemicals and biotechnology company. Financial terms were not disclosed. "At NextPharma, we are very excited at the prospect of adding two new centers of excellence, at Ploermel and Edinburgh, to our manufacturing network, allowing us to further broaden our technology offering for both our existing and new customers. These technologies, combined with the know-how and expertise of the employees at both sites, would provide additional solutions for drug formulations which will benefit patients across the world. On behalf of NextPharma, I look forward to welcoming our future colleagues, and I am confident that together we will continue to further develop and grow NextPharma as a leading and wellrespected European CDMO," Peter Burema, NextPharma CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.